While attending the Alzheimer's Disease / Parkinson's Disease (AD/PD) 2022 Conference in Barcelona, Spain, Dr. Florin Despa gave a talk on our lab's work, which was entitled "The hypothesis of diabetes-associated cerebrovascular amylin deposits blocking β amyloid elimination from the Alzheimer’s disease brain."
Dr. Despa was also interviewed on what could underlie the increased risk of individuals with type-2 diabetes developing dementia. In another interview, he also discusses how hyperamylinemia impairs Aβ removal in the brains of individuals with Alzheimer's disease.
